10x Genomics (NASDAQ:TXG) Given New $13.00 Price Target at Barclays
10x Genomics (NASDAQ:TXG – Free Report) had its price objective increased by Barclays from $12.00 to $13.00 in a research note published on Tuesday morning,Benzinga reports. Barclays currently has an overweight rating on the stock. A number of other research analysts have also issued reports on TXG. JPMorgan Chase & Co. dropped their target price […]
10x Genomics (NASDAQ:TXG – Free Report) had its price objective increased by Barclays from $12.00 to $13.00 in a research note published on Tuesday morning,Benzinga reports. Barclays currently has an overweight rating on the stock. A number of other research analysts have also issued reports on TXG. JPMorgan Chase & Co. dropped their target price […]
